GenoType® MTBDR plus, a new molecular test for multidrug-resistant tuberculosis has recently been approved in Europe. The test, developed by the Foundation for Innovative New Diagnostics (FIND) and Hain Lifescience, offers a fast solution to detect MDR-TB and XDR-TB at a reasonable price, a good condition for the application in poorer countries.
Moving personalized medicine from promise to practice. Siemens Healthcare announces the early study findings of a new imaging biomarker for hypoxic tumors. This clinically problematic cells tend to be less responsive to standard treatment regimens. A probe that measures hypoxia could prove quite a useful tool for oncologists.
The Clinical and Laboratory Standards Institute (CLSI) recently published new guidelines which offer methods to assess test performance when formal proficiency testing programs are not available. Proficiency testing is an important part of quality management in the clinical laboratory and complements internal quality control to help ensure patient test results are valid.
bioMérieux, a world leader in the field of in vitro diagnostics (IVD), offers the most comprehensive diagnostic solution on the market to help hospitals and healthcare facilities fight Healthcare-Associated Infection (HAI).
Professor C Mueller adressed the issue of new biomarkers in acute cardiac care on the ESC on Monday, 1st September. Read his comment in the following.
Unlike regular laboratory analyses, which is performed by clinical pathologists and technicians in the clinical laboratory, Point of Care Testing (POCT) are devices to perform laboratory analyses in the vicinity of the patient by the attending physician or nurses.
The diagnostic work-up of syncope patients often raises the question of how much diagnosis is necessary and what examination methods are really needed. To save time, specialists recommend focusing on determining whether the syncope may be caused by a cardiac problem - a question answered quite easily in many cases. Karl Eberius MD, European Hospital's new correspondent, discussed advice for…
Researchers funded by the European Union have devised OptoLabCard, a system that prepares samples and performs DNA tests on bacteria in a portable, easily used, cost-effective lab-on-a-chip.
A quiet revolution is occurring in clinical laboratory services. In any business model, laboratory services are cost centres, and cost centres can be moved around, services outsourced, amalgamated, contracted out. Globally, diagnostics and laboratory outsourcing are following the already trodden path of information technology.
This summer, California-based Beckman Coulter Inc. began general distribution of its UniCel DxC 880i's integrated system in Europe.
During the XVII International AIDS Conference held in Mexico City this August, keynote speakers from Europe, Latin America and Africa addressed issues including the importance of early detection of HIV infection, the relevance of rapid testing for epidemiology studies, the use of Dried Blood Spots for routine viral-load testing in remote areas, and the experience of South Africa in routine…
Roche reports that, using its NimbleGen CGH arrays, researchers* have identified a recurrent reciprocal genomic rearrangement of chromosomal region 17q12 in foetal samples with congenital anomalies that is also associated with paediatric renal disease and epilepsy.
bioMérieux developed three new microbiology laboratory automation platforms: Two new lab automatic tools and the the UF-1000i, a urinary screening tool to accurately detect and enumerate the bacteria and particles presented in urine specimens.
Engineers from the University of Michigan are seeking to develop a "lab-on-a-chip" kit that people can assemble on their own. It could bring a new generation of instant home tests checking out for illnesses, food contaminants and toxic gases.
The ankle brachial index, a ratio of blood pressure measurements used to indicate the risk of peripheral artery disease and atherosclerosis, may be useful to improve the accuracy of cardiovascular risk prediction, according to a meta-analysis of previous studies.
Siemens Healthcare has developed an sample management system that can be matched with analysis systems for immunology and clinical chemistry. It identifies the test to be performed for which patient by barcodes and automatically feeds the samples to the correct module.
Last month Agendia announced the official opening of the company's new headquarters at Amsterdam's Science Park. The new facilities offer 13,000 square feet of laboratory and office space to support the company's molecular diagnostic cancer testing services and research activities.
So called circulating tumor cells (CTC) seem to be an indicator of the progression and therapy outcome for cancer patients. US- and UK-researchers have shown concurrently that blood tests of CTC's are as reliable as painful biobsies to predict how well patients respond to therapy.
Russia has one of the fastest-growing AIDS epidemic in the world. One reason for this development is unsafe sex of addicts. Therefore sexual behaviour should be considered as an important component in the treatment of drug-dependent people to stop HIV-transmission.
Italy - The genome sequence of Acinetobacter baumannii has been determined by scientists at the Istituto di Tecnologie Biomediche, the Dipartimento di Malattie Infettive at the Istituto Superiore della Sanità and the Dipartimento di Biologia at Roma Tre University. In Italy alone this antibiotic resistant pathogen causes 4,500 to 7,000 deaths annually.
Siemens Healthcare Diagnostics will showcase the combined strengths of Diagnostics Products Corporation (DPC), Bayer HealthCare Diagnostics and Dade Behring.
Lean Laboratory and Lean Automation are vital ingredients for the efficient and productive running of today's modern pathology laboratories. Automation serves as an essential endorsement to Lean, says Paul M Button, Senior Consultant at ValuMetrix, Ortho Clinical Diagnostics*
In today's clinical laboratory the technical staff performs quality inspections that are separate and distinct from normal laboratory testing quality control.
An estimated 92 million Chlamydia trachomatis infections occur annually. Often, this disease presents no clear symptoms. Inverness Medical reports that its Clearview Chlamydia MF test can provide a diagnosis in as little as 30 minutes, so that, during a single visit, a patient can also begin treatment.
Possibilities to co-develop new clinical diagnostic tests for companion diagnostics, metabolic syndrome, oncology and diabetes, are being explored by Siemens Healthcare and Laboratory Corporation of America Holdings (LabCorp).